The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

382

Participants

Timeline

Start Date

October 13, 2014

Primary Completion Date

November 19, 2015

Study Completion Date

November 19, 2015

Conditions
Hypercholesterolemia
Interventions
DRUG

Rosuvastatin

DRUG

Ezetimibe

Trial Locations (20)

Unknown

Chungbuk National University Hospital, Cheongju-si

Yeungnam University Medical Center, Daegu

Chungnam National University Hospital, Daejeon

Dongguk University Ilsan Hospital, Goyang-si

Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si

Gachon University Gil Medical Center, Incheon

Inha University Hospital, Incheon

Seoul National University Bundang Hospital, Seongnam-si

Boramae Hospital, Seoul

Chung-Ang University Hospital, Seoul

Gangnam Severance Hospital, Seoul

Hanyang University Hospital, Seoul

Kangbuk Samsung Hospital, Seoul

Korea University Anam Hospital, Seoul

Korea University Guro Hospital, Seoul

KyungHee University Hospital, Seoul

Seoul National University Hospital, Seoul

Soon Chun Hyang University Hospital Seoul, Seoul

Ajou University Hospital, Suwon

Wonju Severance Christian Hospital, Wŏnju

All Listed Sponsors
lead

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY

NCT03288038 - The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia | Biotech Hunter | Biotech Hunter